Lobe Sciences Ltd. - Undervalued Pioneer in Rare Disease Innovation
Recent Milestones Share Price Performance Lobe Sciences Ltd. (CSE:LBOE) share price performance January 1st 2025 – September 12th 2025. Key Achievements • Altemia (acquired in April 2023) bypasses Phase 3, generated CA $136,205 in 2024 and targets CA $10–20M by 2027 via an exclusive U.S. deal with Pentec